Aprea Therapeutics, Inc. (APRE) SEC Filings — 2024
19 SEC filings for Aprea Therapeutics, Inc. (APRE) in 2024.
Filings
- Aprea Therapeutics Files 8-K — 8-K · Nov 8, 2024
- Aprea Therapeutics Q3 2024 Update: Assets & Liabilities Detailed — 10-Q · Nov 7, 2024
- Aprea Therapeutics Files 8-K — 8-K · Oct 23, 2024
- Aprea Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 10, 2024
- Aprea Therapeutics Files 8-K on Financials and Operations — 8-K · Oct 9, 2024
- Aprea Therapeutics Q2 2024 Update: Assets and Liabilities Detailed — 10-Q · Aug 12, 2024
- Aprea Therapeutics Files 8-K on Shareholder Vote Matters — 8-K · Jun 20, 2024
- Aprea Therapeutics Files 8-K — 8-K · Jun 17, 2024
- Aprea Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 14, 2024
- Aprea Therapeutics Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 25, 2024
- Aprea Therapeutics Files 8-K — 8-K · Apr 10, 2024
- Aprea Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 26, 2024
- Aprea Therapeutics Terminates Material Agreement — 8-K · Mar 12, 2024
- Aprea Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- AIGH Capital Management Holds 9.4% Stake in Aprea Therapeutics — SC 13G/A · Feb 7, 2024
- Aprea Therapeutics Files 8-K for 'Other Events' on Feb 6, 2024 — 8-K · Feb 6, 2024
- Aprea Therapeutics Files 8-K on Financial Condition — 8-K · Feb 2, 2024
- APRE Files 8-K on Material Definitive Agreement — 8-K · Jan 26, 2024
- Aprea Therapeutics Files Routine 8-K on Jan 4, 2024 — 8-K · Jan 4, 2024